Skip to main content

Table 1 Availability of medicines for diabetes and hypertension

From: Medicines availability for non-communicable diseases: the case for standardized monitoring

Medicine

Mean availability (%) of medicine

Peck et al.

WHO/HAI

SARA

All facilities#

Diabetes services

Cardiovascular disease services

N = 24

N = 107

N = 1297

N = 248

N = 316

Diabetes

     

Glibenclamide

 

47*

19*

52

 

Metformin

33

46†

 

57

39

Insulin

17; 8; 8‡

  

34

 

Hypertension

     

Captopril 25 mg

 

48

13

  

Captopril or lisinopril

25

    

ACE inhibitors

    

24

Nifedipine

33

57§

   

Calcium channel blockers

    

29

Atenolol 50 mg

 

48

15

  

Atenolol or propranolol

50

    

Beta-blockers

    

41

Hydrochlorothiazide or bendrofluazide

33

   

31¥

  1. FBO = Faith Based Organization; SR = sustained release formulation.
  2. #Availability of essential tracer medicines is measured across all health facilities surveyed.
  3. *glibenclamide 5 mg tablet.
  4. †metformin 500 mg tablet.
  5. ‡short-acting, intermediate-acting and long-acting insulin assessed separately.
  6. §WHO/HAI survey specified 20 mg sustained-release formulation.
  7. ¥specified as thiazide diuretics.